Aditya BSL Pharma & Hlthcare
Empty
1–7 yearsInvestment Horizon
HNI,MATarget Segments
Empty
Performance and Risk Analysis
Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.
Risk Profile
Standard Deviation12.4%
Maximum Drawdown-15.4% | Oct 2024
Sharpe Ratio0.92
Beta0.80
Upside Capture91%
Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.
Strategy Details
A closer look at the investment thesis, portfolio construction, and current holdings.
Portfolio Holdings Overview
SectoralAllocation
Geographic Allocation
Domestic100%
Top Stock Holdings
CompanySectorAllocation
Torrent Pharmaceuticals LtdServices9.28%
Sun Pharmaceuticals Industries LtdServices8.61%
Apollo Hospitals Enterprise LtdServices6.44%
Cipla LtdServices6.38%
Aurobindo Pharma LtdServices4.52%
Sai Life Sciences LtdServices4.49%
Ajanta Pharma LtdServices4.35%
Mankind Pharma LtdServices3.62%
Dr. Lal PathLabs LtdServices3.51%
Abbott India LtdServices3.26%
Operational & Regulatory Details
What it costs to invest, transaction mechanics, and regulatory disclosures you should know.
Costs and Fees
Total Expense Ratio (TER)2.28%
Exit Load1%
Regulatory & Tax Information
INF209KB1N91
ISINDailyDealing Frequency
BSE Healthcare PR INRBenchmark
LTCG | >1Year 12.5%% on gain above 1.25 Lakh
STCG | <1Year 20%%
Tax Implications (India)